The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ... Nature 486 (7403), 346-352, 2012 | 6212 | 2012 |
Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2293 | 2016 |
Mutational processes molding the genomes of 21 breast cancers S Nik-Zainal, LB Alexandrov, DC Wedge, P Van Loo, CD Greenman, ... Cell 149 (5), 979-993, 2012 | 2130 | 2012 |
The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1942 | 2012 |
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1887* | 2020 |
The life history of 21 breast cancers S Nik-Zainal, P Van Loo, DC Wedge, LB Alexandrov, CD Greenman, ... Cell 149 (5), 994-1007, 2012 | 1601 | 2012 |
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters T Hung, Y Wang, MF Lin, AK Koegel, Y Kotake, GD Grant, HM Horlings, ... Nature genetics 43 (7), 621-629, 2011 | 1384 | 2011 |
Complex landscapes of somatic rearrangement in human breast cancer genomes PJ Stephens, DJ McBride, ML Lin, I Varela, ED Pleasance, JT Simpson, ... Nature 462 (7276), 1005-1010, 2009 | 1021 | 2009 |
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway WA Freed-Pastor, H Mizuno, X Zhao, A Langerød, SH Moon, ... Cell 148 (1), 244-258, 2012 | 916 | 2012 |
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast H Zhao, A Langerød, Y Ji, KW Nowels, JM Nesland, R Tibshirani, ... Molecular biology of the cell 15 (6), 2523-2536, 2004 | 495 | 2004 |
TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer A Langerød, H Zhao, Ø Borgan, JM Nesland, IRK Bukholm, T Ikdahl, ... Breast cancer research 9, 1-16, 2007 | 369 | 2007 |
TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance L Silwal-Pandit, HKM Vollan, SF Chin, OM Rueda, S McKinney, T Osako, ... Clinical Cancer Research 20 (13), 3569-3580, 2014 | 328 | 2014 |
Mutation of GATA3 in human breast tumors J Usary, V Llaca, G Karaca, S Presswala, M Karaca, X He, A Langerød, ... Oncogene 23 (46), 7669-7678, 2004 | 319 | 2004 |
p53 polymorphism and risk of cervical cancer A Storey, M Thomas, A Kalita, C Harwood, D Gardiol, F Mantovani, ... Nature 396 (6711), 532-532, 1998 | 225 | 1998 |
Oslo Breast Cancer Consortium (OSBREAC). The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 191 | 2012 |
TP53 mutations in breast and ovarian cancer L Silwal-Pandit, A Langerød, AL Børresen-Dale Cold Spring Harbor perspectives in medicine 7 (1), a026252, 2017 | 176 | 2017 |
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients HG Russnes, HKM Vollan, OC Lingjærde, A Krasnitz, P Lundin, B Naume, ... Science translational medicine 2 (38), 38ra47-38ra47, 2010 | 176 | 2010 |
Discovery and validation of breast cancer subtypes AV Kapp, SS Jeffrey, A Langerød, AL Børresen-Dale, W Han, DY Noh, ... BMC genomics 7, 1-15, 2006 | 171 | 2006 |
EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer AM Pietersen, HM Horlings, M Hauptmann, A Langerød, A Ajouaou, ... Breast Cancer Research 10, 1-12, 2008 | 164 | 2008 |
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas A Langerød, IRK Bukholm, A Bregard, PE Lønning, TI Andersen, ... Cancer Epidemiology Biomarkers & Prevention 11 (12), 1684-1688, 2002 | 160 | 2002 |